Abstract
Percutaneous transluminal coronary angioplasty (PTCA)1 is an accepted treatment for selected patients with isolated single-vessel obstructive coronary disease.2–4 The use of PTCA has been successful in multivessel coronary artery disease (MVD) patients.5–7 The demonstrated safety and efficacy of angioplasty in patients with isolated proximal coronary stenosis(es) permitted its evaluation in patients with extensive coronary disease.7–14 However, the continuous merging of words, which only ensure the reader, has led us to define the two major subgroups most often discussed so as to clarify what has happened. The acute outcome and follow-up of PTCA in MVD patients who underwent single- or multiple-lesion angioplasty (group I), and in patients (with single or multivessel coronary disease) who underwent multiple lesion angioplasty (MLA; group II) is discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
